Processa Pharmaceuticals Gross Margin Growth & History (PCSA)

Processa Pharmaceuticals's gross margin was 100.00% for fiscal 2016.

View full Processa Pharmaceuticals company overview

Processa Pharmaceuticals annual gross margin history

Processa Pharmaceuticals annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20162016-12-31100.00%+110.98 pp
20152015-12-31−10.98%−48.66 pp
20142014-12-3137.68%−2.16 pp
20132013-12-3139.84%+9.19 pp
20122012-12-3130.65%

Processa Pharmaceuticals gross margin trends

Across the available reported history, Processa Pharmaceuticals's gross margin increased from −10.98% to 100.00%, a change of +110.98 percentage points. The latest reported quarter, Q1 2016, shows 100.00%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Processa Pharmaceuticals filings at SEC.gov ↗